Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2024 is 8.63% vs 30.64% in Dec 2023
Consolidate Net Profit
YoY Growth in quarter ended Dec 2024 is 298.25% vs -111.77% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2024 is 5,406.67% vs 98.26% in Dec 2023
Interest
YoY Growth in quarter ended Dec 2024 is 16.47% vs -11.46% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023
Compare Quarterly Results Of Panacea Biotec With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2024 is 10.95% vs 27.33% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 8.63% vs 30.64% in Dec 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2024 is -4.03% vs 129.66% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 298.25% vs -111.77% in Dec 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2024 is 13.71% vs 150.04% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 5,406.67% vs 98.26% in Dec 2023
Quarterly - Interest
QoQ Growth in quarter ended Dec 2024 is 1.02% vs 12.64% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 16.47% vs -11.46% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023